PerCP - anti Human CD98 - FG1/8

PerCP - anti Human CD98 - FG1/8

Catalog Number:
A001108936IMM
Mfr. No.:
98PP-100T
Price:
$635
  • Size:
    100 test
    Quantity:
    Add to Cart:
      • Overview
        • This antibody reacts with the CD98 antigen, which is broadly expressed on peripheral blood lymphocytes, monocytes and granulocytes (low) .It is also expressed on non-hematopoietic cells. Reports suggest that CD98 may be involved in the regulation of cellular activation. CD98 is up-regulated on leukocytes and in inflammatory lesions, and strongly expressed by neoplastic cells. However, expression is not hematopoietic specific. CD98 is expressed in HUVECS and at low levels in resting peripheral blood T-lymphocytes and quiescent fibroblasts. Also it is expressed in fetal liver and in the astrocytic process of primary astrocytic gliomas, in retinal endothelial cells and in the intestinal epithelial cell line C2BBe1.

          Please contact us at for specific academic pricing.

      • Properties
        • Isotype
          IgG1
          Reactivity
          human
          Clone
          FG1/8
          Immunogen
          T cells from leukemic HPB-ALL
          Conjugate
          PerCP
          Concentration
          Please refer to the Certificate of Analysis for the lot-specific concentration.
          Molecular Weight
          125 kDa
          Regulatory Status
          RUO
          Antigen
          4F2, FRP-1, RL-388, 4F2hc, 4F2 heavy chain antigen, Lymphocyte activation antigen 4F2 large subunit, Solute carrier family 3 member 2 (Gene ID:6520)

          * For research use only.

      • Applications
        • Application
          Flow Cytometry
          Application Description
          CD98, clone FG1/8, is a mAb intended for the identification of human leukocyte lineages. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/106 cells.

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.